Search research articles
Contact Us
Filters
Showing results (41-50 of 53) with videos related to
Page
of 6
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 1995
Pharmacological effects of GR138950, a novel angiotensin AT1 receptor antagonist
A Hilditch, A A Hunt, A Travers, et al.
Applied and Environmental Microbiology
|
November 5, 1997
Detection of Mycobacterium ulcerans in environmental samples during an outbreak of ulcerative disease
B C Ross, P D Johnson, F Oppedisano, et al.
Journal of Medicinal Chemistry
|
November 11, 1994
Orally active non-peptide fibrinogen receptor (GpIIb/IIIa) antagonists: identification of 4-[4-[4-(aminoiminomethyl)phenyl]-1-piperazinyl]-1-piperidineacetic acid as a long-acting, broad-spectrum antithrombotic agent
C D Eldred, B Evans, S Hindley, et al.
Journal of Medicinal Chemistry
|
October 30, 1992
Conformationally constrained tachykinin analogues: potent and highly selective neurokinin NK-2 receptor agonists
M J Deal, R M Hagan, S J Ireland, et al.
British Journal of Pharmacology
|
January 1, 1994
Cardiovascular effects of GR117289, a novel angiotensin AT1 receptor antagonist
A Hilditch, A A Hunt, C J Gardner, et al.
Journal of Medicinal Chemistry
|
September 16, 1994
Bromobenzofuran-based non-peptide antagonists of angiotensin II: GR138950, a potent antihypertensive agent with high oral bioavailability
D B Judd, M D Dowle, D Middlemiss, et al.
British Journal of Pharmacology
|
December 1, 1992
Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist
M J Robertson, J C Barnes, G M Drew, et al.
Biochemical Society Transactions
|
December 1, 1990
Structure-activity relationships of some synthetic atrial natriuretic peptide analogues
A J Crame, M G Dodds, P G Dolamore, et al.
Journal of Medicinal Chemistry
|
July 10, 1992
Highly potent and selective heptapeptide antagonists of the neurokinin NK-2 receptor
A B McElroy, S P Clegg, M J Deal, et al.
The Journal of Biological Chemistry
|
June 15, 1992
Squalestatin 1, a potent inhibitor of squalene synthase, which lowers serum cholesterol in vivo
A Baxter, B J Fitzgerald, J L Hutson, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 53) with videos related to
Sort By:
Page
of 6
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 1995
Pharmacological effects of GR138950, a novel angiotensin AT1 receptor antagonist
A Hilditch, A A Hunt, A Travers, et al.
Applied and Environmental Microbiology
|
November 5, 1997
Detection of Mycobacterium ulcerans in environmental samples during an outbreak of ulcerative disease
B C Ross, P D Johnson, F Oppedisano, et al.
Journal of Medicinal Chemistry
|
November 11, 1994
Orally active non-peptide fibrinogen receptor (GpIIb/IIIa) antagonists: identification of 4-[4-[4-(aminoiminomethyl)phenyl]-1-piperazinyl]-1-piperidineacetic acid as a long-acting, broad-spectrum antithrombotic agent
C D Eldred, B Evans, S Hindley, et al.
Journal of Medicinal Chemistry
|
October 30, 1992
Conformationally constrained tachykinin analogues: potent and highly selective neurokinin NK-2 receptor agonists
M J Deal, R M Hagan, S J Ireland, et al.
British Journal of Pharmacology
|
January 1, 1994
Cardiovascular effects of GR117289, a novel angiotensin AT1 receptor antagonist
A Hilditch, A A Hunt, C J Gardner, et al.
Journal of Medicinal Chemistry
|
September 16, 1994
Bromobenzofuran-based non-peptide antagonists of angiotensin II: GR138950, a potent antihypertensive agent with high oral bioavailability
D B Judd, M D Dowle, D Middlemiss, et al.
British Journal of Pharmacology
|
December 1, 1992
Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist
M J Robertson, J C Barnes, G M Drew, et al.
Biochemical Society Transactions
|
December 1, 1990
Structure-activity relationships of some synthetic atrial natriuretic peptide analogues
A J Crame, M G Dodds, P G Dolamore, et al.
Journal of Medicinal Chemistry
|
July 10, 1992
Highly potent and selective heptapeptide antagonists of the neurokinin NK-2 receptor
A B McElroy, S P Clegg, M J Deal, et al.
The Journal of Biological Chemistry
|
June 15, 1992
Squalestatin 1, a potent inhibitor of squalene synthase, which lowers serum cholesterol in vivo
A Baxter, B J Fitzgerald, J L Hutson, et al.
Page
of 6